The last year of this decade has been a very successful one for LS CancerDiag, where many important milestones were achieved, and the basis was laid for strong growth over the coming years. To gear up for a promising 2020, LS CancerDiag has strengthened its management team to take the next step towards its ambitious vision to make DiagMMR® the Gold standard for Lynch syndrome detection.
Click below to read the full press release: